Clinical Trial Update: Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients. [Phase 4]

View source ↗

Summary

Clinical trial update on early initiation of low-dose tirofiban for primary percutaneous coronary intervention in STEMI patients (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• tirofiban (tirofiban)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: ST Elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN